Juliet E. Vanegmond, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9733 Healthway Drive, Berlin, MD 21811 Phone: 410-641-9109 Fax: 410-629-1203 |
Gregory W Stamnas, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9733 Healthway Drive, Berlin, MD 21811 Phone: 410-641-9109 Fax: 410-629-1203 |
News Archive
As part of a campaign to raise awareness of prostate cancer, men drinking in Glasgow pubs will be served up advice on the disease along with their pints.
Teen-agers and young adults who intentionally hurt themselves engage in such behavior based, in part, on how they experience pain and their emotional distress, according to a Rutgers study.
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving antiarrhythmic drugs, the standard first-line treatment.
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
› Verified 8 days ago